Omnicell, Inc. (OMCL)

Market Cap	1.94B
Revenue (ttm)	1.18B
Net Income (ttm)	19.92M
Shares Out	44.88M
EPS (ttm)	0.43
PE Ratio	101.71
Forward PE	24.56
Dividend	n/a
Ex-Dividend Date	n/a

Volume	551,088
Open	43.93
Previous Close	43.86
Day's Range	42.60 - 44.00
52-Week Range	22.66 - 47.69
Beta	0.83
Analysts	Buy
Price Target	43.00 (-0.62%)
Earnings Date	Feb 5, 2026

About OMCL

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital; and specialized automated dispensing systems for hospitals, health systems, and post-acute care facilities. It also provides central pharmacy disp...

• Industry: Health Information Services
• Sector: Healthcare
• IPO Date: Aug 7, 2001
• Employees: 3,670
• Stock Exchange: NASDAQ
• Ticker Symbol: OMCL
• Website: https://www.omnicell.com

Analyst Summary

According to 5 analysts, the average rating for OMCL stock is "Buy." The 12-month stock price target is $43.0, which is a decrease of -0.62% from the latest price.

Price Target

$43.0

(-0.62% downside)

Analyst Consensus: Buy